Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Melinta Therapeutics, Inc. (NASDAQ:MLNT)

14.45
Delayed Data
As of 4:00pm ET
 -0.50 / -3.34%
Today’s Change
10.25
Today|||52-Week Range
39.25
+3.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash96.5M99.1M153.8M231.6M
 
 
 
 
 
Short Term Investment Cash26.4M2.6M54.7M77.8M
 
 
 
 
 
Cash & Short Term Investments96.5M99.1M153.8M231.6M
 
 
 
 
 
 
ReceivablesReceivables1.6M2.4M7.6M6.2M
 
 
 
 
 
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses407.9K3.4M572.6K579.0K
 
 
 
 
 
Current Assets98.5M104.9M162.0M238.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross336.1K303.0K348.8K--
 
 
 
 
Depreciation-198.4K-189.9K-259.1K--
 
 
 
 
Other Assets333.0K0.0073.2K173.0K
 
 
 
 
Total Assets99.0M105.3M162.1M238.5M
 
 
 
 
 
 
LiabilitiesAccounts Payable6.3M11.9M9.6M15.7M
 
 
 
 
 
Short Term Debt2.2M3.6M4.4M6.7M
 
 
 
 
 
Accrued Expenses208.7K788.0K863.9K2.3M
 
 
 
 
 
Other Current Liabilities1.3M1.0M1.5M2.9M
 
 
 
 
 
Other Liabilities10.9M18.1M17.9M29.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt12.5M14.9M15.3M8.7M
 
 
 
 
 
Total Liabilities29.0M44.3M44.5M55.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity70.0M61.0M117.7M183.3M
 
 
 
 
 
Total Shareholder Equity70.0M61.0M117.7M183.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding6.6M7.5M8.8M10.5M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.